Eupraxia Pharmaceuticals is trading 5.66% down at $7.34 with the market open amid broader oil-price and Treasury-yield concerns.
- No clear company-specific announcement for October 8 was identified; the latest surfaced company news was September 30 trial data.
- Broader pressure is consistent with oil-price and Treasury-yield concerns amid geopolitical tensions, including reported Houthi attacks on Saudi airports.
- Rising oil and yields have been linked to renewed inflation fears in markets; supplied sector context reports healthcare shares lower.